Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 6Breast Neoplasms, Male 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Meningioma 1Meningeal Carcinomatosis 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Infections 1Graft vs Host Disease 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Brain Neoplasms 1

Interventions

Cyclophosphamide 5Radiotherapy 4Cyclosporine 4Antilymphocyte Serum 4Busulfan 3fludarabine phosphate 2Therapeutics 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1sargramostim 1Whole-Body Irradiation 1Voriconazole 1Thalidomide 1Polymerase Chain Reaction 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Interferon alpha-2 1Immunoenzyme Techniques 1Health 1Fluconazole 1Flow Cytometry 1Fibroblast Growth Factor 7 1Etoposide 1Dexamethasone 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Graft vs Host Disease × Immunoenzyme Techniques × Clear all
NCT00462657 2013-08-26

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

National Cancer Institute (NCI)

Phase NA Unknown
200 enrolled
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Infections, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡